Cetrorelix Acetate for Healthy Subjects (HS)
Study Summary
This trial will look at the effects of testosterone on the autonomic nervous system (which controls involuntary body functions like heart rate) and blood vessels in men.
Treatment Effectiveness
Study Objectives
3 Primary · 1 Secondary · Reporting Duration: After 7 days GnRH antagonist alone and 7 days GnRH antagonist + Testosterone
Trial Safety
Trial Design
2 Treatment Groups
GnRH antagonist alone
1 of 2
GnRH antagonist + Testosterone add-back
1 of 2
Experimental Treatment
20 Total Participants · 2 Treatment Groups
Primary Treatment: Cetrorelix Acetate · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 65 · Male Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 28th, 2021
Last Reviewed: November 2nd, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| Washington | 80.0% |
| Virginia | 20.0% |
How old are they?
| 18 - 65 | 66.7% |
| 65+ | 33.3% |
What site did they apply to?
| the University of Western Ontario | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 33.3% |
| Met criteria | 66.7% |